Karyopharm Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KPTI research report →
About the company
Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses.
- CEO
- Richard A. Paulson
- IPO
- 2013
- Employees
- 279
- HQ
- Newton, MA, US
Price Chart
- Market Cap
- $217.56M
- P/E
- -0.65
- P/S
- 1.44
- P/B
- -0.80
- EV/EBITDA
- -2.42
- Div Yield
- 0.00%
- Gross Margin
- 96.03%
- Op Margin
- -55.73%
- Net Margin
- -129.02%
- ROE
- 73.11%
- ROIC
- -177.79%
- Revenue
- $146.07M · 0.57%
- Net Income
- $-196,039,000 · -156.52%
- EPS
- $-17.93 · -90.54%
- Op Income
- $-90,707,000
- FCF YoY
- 40.95%
- 52W High
- $10.99
- 52W Low
- $3.65
- 50D MA
- $8.95
- 200D MA
- $7.42
- Beta
- 0.81
- Avg Volume
- 493.28K
Get TickerSpark's AI analysis on KPTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 21, 26 | Oliger Christy J. | other | 15,508 |
| May 21, 26 | PAKIANATHAN DEEPIKA | other | 15,508 |
| May 21, 26 | Schor Chen | other | 15,508 |
| May 21, 26 | Su Zhen | other | 15,508 |
| May 21, 26 | BOHLIN GAREN G | other | 15,508 |
| May 21, 26 | Greene Barry E | other | 15,508 |
| May 13, 26 | Poulton Stuart | other | 896 |
| May 14, 26 | Poulton Stuart | sell | 403 |
| May 13, 26 | Rangwala Reshma | other | 947 |
| May 14, 26 | Rangwala Reshma | sell | 408 |
Our KPTI coverage
Recent articles, reports, and earnings notes.
No research on KPTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KPTI report →Similar companies
Peers in the same neighborhood.